Tech is Characterized by Power – Law. Lots of Output, Very Few Winners

There’s 200,000 new apps that come out each month, but very few will be successful. There’s 8-10 genetic marker tests that come out each day, very few if any are decipherable/can be tied to as an indicator of disease. There’s ~60k genetic tests on the market. 3000 types of steel exist, and 80% of them… Read More Tech is Characterized by Power – Law. Lots of Output, Very Few Winners

Focus May Be Your Worst Enemy in Biotech R&D Investing

My Fascination With Mega Research Initiatives I like reading biotech research and how the industry brings products to market. I discovered something unusual about the mega-initiatives that try to tackle some of humanity’s biggest diseases. Some Recent Mega Initiatives by Powerful Billionaires I was thinking about this a lot lately as the news has seen rise… Read More Focus May Be Your Worst Enemy in Biotech R&D Investing

The Germans, Their Renewables, and Much Ado About Nothing

There’s been some recent news with positive sentiment toward Solar Power in Germany creating super positive outcomes, but I believe it’s worth pointing out that this is much ado about nothing. Germans produce power semi randomly. They then put strain on the power-grid and pretend it’s renewable. Customers didn’t and won’t get any money from… Read More The Germans, Their Renewables, and Much Ado About Nothing

The Lack of Substance in Liz Parrish’s Bio-Viva Claims

I’ve gotten about 60 messages about Liz Parrish’s outfit and the test on herself to lengthen her telomeres. I don’t think there’s any substance to any of her claims and life extension. (Her article: http://bioviva-science.com/…/first-gene-therapy-successful…/) A few very critical questions: What if anything does telomere lengthening have to do with life extension? (It’s multi-factorial) Correlation… Read More The Lack of Substance in Liz Parrish’s Bio-Viva Claims